A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues

• Charlotte Welinder,

  Affiliations Oncology and Pathology, Dept. of Clinical Sciences, Lund University, Lund, Sweden, Centre of Excellence in Biological and Medical Mass Spectrometry “CEBMMS”, Biomedical Centre D13, Lund University, Lund, Sweden

  ⨯
• Krzysztof Pawłowski,

  Affiliation Warsaw University of Life Sciences, Warsaw, Poland

  ⨯
• Yutaka Sugihara,

  Affiliation Oncology and Pathology, Dept. of Clinical Sciences, Lund University, Lund, Sweden

  ⨯
• Maria Yakovleva,

  Affiliations National Korányi Institute of Pulmonology, Budapest, Hungary, Clinical Protein Science & Imaging, Biomedical Centre, Dept. of Biomedical Engineering, Lund University, Lund, Sweden

  ⨯
• Göran Jönsson,

  Affiliation Oncology and Pathology, Dept. of Clinical Sciences, Lund University, Lund, Sweden

  ⨯
• Christian Ingvar,

  Affiliation Surgery, Dept. of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden

  ⨯
• Lotta Lundgren,

  Affiliations Oncology and Pathology, Dept. of Clinical Sciences, Lund University, Lund, Sweden, Skåne University Hospital, Lund, Sweden

  ⨯
• Bo Baldetorp,

  Affiliation Oncology and Pathology, Dept. of Clinical Sciences, Lund University, Lund, Sweden

  ⨯
• Håkan Olsson,

  Affiliations Oncology and Pathology, Dept. of Clinical Sciences, Lund University, Lund, Sweden, Skåne University Hospital, Lund, Sweden, Cancer Epidemiology, Dept. of Clinical Sciences, Lund University, Lund, Sweden

  ⨯
• Melinda Rezeli,

  Affiliation Clinical Protein Science & Imaging, Biomedical Centre, Dept. of Biomedical Engineering, Lund University, Lund, Sweden

  ⨯
• Bo Jansson,

  Affiliation Oncology and Pathology, Dept. of Clinical Sciences, Lund University, Lund, Sweden

  ⨯
• Thomas Laurell,

  Affiliations Centre of Excellence in Biological and Medical Mass Spectrometry “CEBMMS”, Biomedical Centre D13, Lund University, Lund, Sweden, Clinical Protein Science & Imaging, Biomedical Centre, Dept. of Biomedical Engineering, Lund University, Lund, Sweden

  ⨯
• Thomas Fehniger,

  Affiliations Oncology and Pathology, Dept. of Clinical Sciences, Lund University, Lund, Sweden, Centre of Excellence in Biological and Medical Mass Spectrometry “CEBMMS”, Biomedical Centre D13, Lund University, Lund, Sweden

  ⨯
• Balazs Döme,

  Affiliations National Korányi Institute of Pulmonology, Budapest, Hungary, Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria

  ⨯
• Johan Malm,

  Affiliation Section for Clinical Chemistry, Dept. of Laboratory Medicine, Lund University, Skåne University Hospital in Malmö, Malmö, Sweden

  ⨯
• Elisabet Wieslander,

  Affiliation Oncology and Pathology, Dept. of Clinical Sciences, Lund University, Lund, Sweden

  ⨯
• Toshihide Nishimura,

  Affiliations Oncology and Pathology, Dept. of Clinical Sciences, Lund University, Lund, Sweden, Centre of Excellence in Biological and Medical Mass Spectrometry “CEBMMS”, Biomedical Centre D13, Lund University, Lund, Sweden, First Dept. of Surgery, Tokyo Medical University, Tokyo, Japan

  ⨯
•  [ ... ],
• György Marko-Varga

  * E-mail: Gyorgy.Marko-Varga@bme.lth.se

  Affiliations Centre of Excellence in Biological and Medical Mass Spectrometry “CEBMMS”, Biomedical Centre D13, Lund University, Lund, Sweden, Clinical Protein Science & Imaging, Biomedical Centre, Dept. of Biomedical Engineering, Lund University, Lund, Sweden, First Dept. of Surgery, Tokyo Medical University, Tokyo, Japan

  ⨯
• [ view all ]
• [ view less ]